{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Untargeted Bottom-Up Proteomics 实验流程笔记\n",
    "\n",
    "## 实验总览 | Workflow Overview\n",
    "\n",
    "本流程基于 label-free bottom-up proteomics 和 data-dependent acquisition (DDA)，用于大规模蛋白质鉴定和定量。  \n",
    "This workflow uses label-free bottom-up proteomics with data-dependent acquisition (DDA) to identify and quantify proteins from complex samples.\n",
    "\n",
    "---\n",
    "\n",
    "## 1. 样品准备 | Sample Preparation\n",
    "\n",
    "1. 细胞裂解 / 组织匀浆：提取总蛋白  \n",
    "   Cell lysis / tissue homogenization: Extract total protein \n",
    "\n",
    "2. 蛋白定量：常用 BCA 法  \n",
    "   Protein quantification: BCA assay is commonly used  \n",
    "\n",
    "3. 蛋白变性：使用尿素 / 去污剂展开结构  \n",
    "   Denaturation: Use urea or detergents to unfold protein structures  \n",
    "\n",
    "4. 还原与烷基化：断开二硫键并封闭巯基  \n",
    "   Reduction and alkylation: Break disulfide bonds (DTT/TCEP) and block thiols (IAA)  \n",
    "\n",
    "5. 酶解：用 trypsin/LysC 消化生成肽段  \n",
    "   Proteolysis: Digest proteins into peptides using trypsin and LysC  \n",
    "\n",
    "6. 去除杂质 / 清洗：固相萃取去除盐和变性剂  \n",
    "   Cleanup: Solid-phase extraction (SPE) removes salts and denaturants  \n",
    "\n",
    "7. 重溶肽段：使用 LC-MS 兼容缓冲液重溶  \n",
    "   Peptide resuspension: Use LC-MS compatible solvent (e.g., 0.1% FA)  \n",
    "\n",
    "---\n",
    "\n",
    "## 2. LC-MS/MS 分析 | LC-MS/MS Analysis\n",
    "\n",
    "- 液相色谱分离：根据疏水性分离肽段  \n",
    "  Liquid chromatography (LC): Separates peptides based on hydrophobicity  \n",
    "\n",
    "- 电喷雾电离（ESI）：将肽段带电  \n",
    "  Electrospray ionization (ESI): Ionizes peptides from liquid to gas phase  \n",
    "\n",
    "- MS1 扫描：记录所有前体离子（m/z 和强度）  \n",
    "  MS1 scan: Measures precursor ions (m/z and intensity)  \n",
    "\n",
    "- MS2 扫描：选取前体离子碎裂生成碎片谱图  \n",
    "  MS2 scan: Selects and fragments precursors to generate MS/MS spectra  \n",
    "\n",
    "---\n",
    "\n",
    "## 3. DDA 数据采集模式 | Data-Dependent Acquisition\n",
    "\n",
    "- MS1 中选择最强信号的离子进行碎裂  \n",
    "  Top N selection from MS1 for fragmentation  \n",
    "\n",
    "- 使用动态排除防止重复采集  \n",
    "  Dynamic exclusion prevents repeated fragmentation  \n",
    "\n",
    "- 常用碎裂方式为 HCD 或 CID  \n",
    "  HCD or CID are typical fragmentation methods  \n",
    "\n",
    "---\n",
    "\n",
    "## 4. 肽段鉴定 | Peptide Identification\n",
    "\n",
    "- 使用数据库搜索（如 SEQUEST, Andromeda）匹配 MS2 谱图  \n",
    "  Database search tools (e.g., SEQUEST, Andromeda) match MS2 spectra to theoretical peptides  \n",
    "- 设置 FDR 控制假阳性率（常用 1%）  \n",
    "  False Discovery Rate (FDR) is used to control identification quality (typically 1%)  \n",
    "\n",
    "---\n",
    "\n",
    "## 5. 蛋白定量 | Protein Quantification\n",
    "\n",
    "- Label-Free Quantification (LFQ)：使用 MS1 色谱峰面积估算肽段丰度  \n",
    "  LFQ estimates peptide abundance from MS1 chromatographic peak area\n",
    "\n",
    "- 限制：不同肽段间信号不可直接比较  \n",
    "  Limitation: Intensity is peptide-specific and not directly comparable between peptides  \n",
    "\n",
    "---\n",
    "\n",
    "## 6. 蛋白推断 | Protein Inference\n",
    "\n",
    "- 多个肽段整合到蛋白组（protein group）中  \n",
    "  Peptides are assigned to protein groups  \n",
    "- 使用 parsimonious 原则，找出最小蛋白集合解释所有肽段  \n",
    "  Parsimonious inference selects the minimal set of proteins to explain observed peptides  \n",
    "\n",
    "---\n",
    "\n",
    "## 7. 统计分析与功能注释 | Statistical Analysis & Functional Interpretation\n",
    "\n",
    "- 差异分析：使用 Perseus、MSstats、R/Python 工具  \n",
    "  Differential analysis: Tools include Perseus, MSstats, R/Python  \n",
    "- 功能注释：GO 富集、KEGG 通路、STRING 网络  \n",
    "  Biological interpretation: GO enrichment, KEGG pathway, STRING networks  \n",
    "\n",
    "---\n",
    "\n",
    "## 总流程总结 | Final Workflow Summary\n",
    "\n",
    "| 步骤 Step | 中文 | English |\n",
    "|----------|------|---------|\n",
    "| 1 | 裂解 & 变性 | Lysis & Denaturation |\n",
    "| 2 | 还原 & 烷基化 | Reduction & Alkylation |\n",
    "| 3 | 酶解蛋白质 | Protease digestion |\n",
    "| 4 | 去杂质 & 重溶 | Cleanup & Resuspension |\n",
    "| 5 | LC-MS/MS 分析 | LC-MS/MS analysis |\n",
    "| 6 | 谱图搜索与鉴定 | Spectral search & ID |\n",
    "| 7 | 相对定量分析 | Relative quantification |\n",
    "| 8 | 蛋白推断 | Protein inference |\n",
    "| 9 | 功能注释 | Functional interpretation |\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# BCA 蛋白浓度测定法（BCA Assay）\n",
    "\n",
    "## 1. 原理 | Principle\n",
    "\n",
    "BCA assay（Bicinchoninic Acid Assay）是一种用于测定蛋白质浓度的比色分析方法。  \n",
    "The BCA assay is a colorimetric method for determining protein concentration.\n",
    "\n",
    "它基于两步反应：  \n",
    "It involves two sequential reactions:\n",
    "\n",
    "1. **Biuret 反应**（铜还原）| **Biuret Reaction (Cu²⁺ reduction)**  \n",
    "   在碱性条件下，蛋白质将 Cu²⁺ 还原为 Cu⁺  \n",
    "   Proteins reduce Cu²⁺ to Cu⁺ under alkaline conditions.\n",
    "\n",
    "2. **BCA 络合反应** | **BCA-Cu⁺ Complex Formation**  \n",
    "   Cu⁺ 与 BCA（Bicinchoninic Acid）络合生成紫色化合物，在 562 nm 处吸光度最强。  \n",
    "   Cu⁺ reacts with BCA to form a purple-colored complex that absorbs strongly at 562 nm.\n",
    "\n",
    "---\n",
    "\n",
    "## 2. 操作步骤 | Experimental Steps\n",
    "\n",
    "| 步骤 Step | 中文说明 | English Description |\n",
    "|-----------|----------|---------------------|\n",
    "| 1 | 配制 BCA 工作液 | Prepare BCA working reagent |\n",
    "| 2 | 加入蛋白样品（待测） | Add protein sample into wells |\n",
    "| 3 | 加入 BCA 试剂 | Add BCA reagent to each well |\n",
    "| 4 | 孵育（37–60°C，30 分钟） | Incubate at 37–60°C for 30 minutes |\n",
    "| 5 | 读取吸光度（562 nm） | Measure absorbance at 562 nm |\n",
    "| 6 | 根据标准曲线计算浓度 | Calculate protein concentration from standard curve |\n",
    "\n",
    "---\n",
    "\n",
    "## 3. 常用标准品 | Common Standard\n",
    "\n",
    "- **BSA（牛血清白蛋白）** 作为标准品制备标准曲线  \n",
    "  Bovine Serum Albumin (BSA) is used as the standard protein for calibration.\n",
    "\n",
    "---\n",
    "\n",
    "## 4. 优点与注意事项 | Advantages and Considerations\n",
    "\n",
    "| 项目 Item | 中文说明 | English Description |\n",
    "|-----------|----------|---------------------|\n",
    "| 灵敏度 | 检测下限约 0.5 µg/mL | Sensitivity down to ~0.5 µg/mL |\n",
    "| 稳定性 | 紫色产物稳定数小时 | Color product is stable for hours |\n",
    "| 兼容性 | 可容忍多种缓冲液、去污剂 | Tolerates many buffers and detergents |\n",
    "| 干扰物 | DTT、TCEP、EDTA 可能干扰反应 | Reducing agents (DTT, TCEP) and chelators (EDTA) may interfere |\n",
    "\n",
    "---\n",
    "\n",
    "## 5. 参考文献 | References\n",
    "\n",
    "Smith, P. K., et al. (1985). Measurement of protein using bicinchoninic acid. *Analytical Biochemistry*, **150**(1), 76–85.  \n",
    "https://doi.org/10.1016/0003-2697(85)90442-7\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# BCA Assay 原理讲解\n",
    "\n",
    "## 为什么 BCA assay 能测出蛋白质浓度？  \n",
    "**Why can the BCA assay measure protein concentration?**\n",
    "\n",
    "BCA（Bicinchoninic Acid）法测蛋白质，是基于蛋白质**可还原金属离子**这一性质，配合 BCA 显色的化学反应。  \n",
    "The BCA assay is based on the ability of proteins to **reduce copper ions**, combined with the colorimetric detection by BCA.\n",
    "\n",
    "---\n",
    "\n",
    "## 原理分为两步 | Two-Step Mechanism\n",
    "\n",
    "### 1. Biuret 反应：蛋白还原铜 | Biuret Reaction: Protein Reduces Cu²⁺\n",
    "\n",
    "在碱性环境下（通常为碱性缓冲液），蛋白质中的以下结构会将二价铜离子（Cu²⁺）还原为一价铜离子（Cu⁺）：  \n",
    "Under alkaline conditions, proteins reduce Cu²⁺ to Cu⁺ through:\n",
    "\n",
    "- 肽键本身（尤其是两个以上连续肽键）；  \n",
    "  **Peptide bonds**, especially dipeptides or longer chains  \n",
    "- 含硫或芳香氨基酸（如 Cys, Trp, Tyr）  \n",
    "  Amino acid residues like **cysteine, tryptophan, tyrosine**\n",
    "\n",
    "生成的 Cu⁺ 量与蛋白质量成正比。  \n",
    "The amount of Cu⁺ generated is **proportional to the protein content**.\n",
    "\n",
    "---\n",
    "\n",
    "### 2. Cu⁺ 与 BCA 络合显色 | Cu⁺ Forms a Purple Complex with BCA\n",
    "\n",
    "随后，Cu⁺ 与两分子 BCA 形成紫色络合物，在 562 nm 波长具有强吸收：  \n",
    "The Cu⁺ ion forms a **purple complex** with two BCA molecules, which absorbs strongly at **562 nm**.\n",
    "\n",
    "$$\n",
    "\\text{Protein amount} \\propto \\text{Cu}^{+} \\propto \\text{Absorbance}_{562}\n",
    "$$\n",
    "\n",
    "紫色深浅与蛋白质浓度线性相关，可通过标准曲线反推出未知样品浓度。  \n",
    "The intensity of the purple color correlates linearly with protein concentration, allowing quantification via a standard curve.\n",
    "\n",
    "---\n",
    "\n",
    "## 为什么不直接测 Cu⁺？| Why not measure Cu⁺ directly?\n",
    "\n",
    "- Cu⁺ 本身无色，不能直接测吸光度；  \n",
    "  **Cu⁺ is colorless** and does not absorb visible light.  \n",
    "- BCA 与 Cu⁺ 形成的络合物稳定且易检测；  \n",
    "  The **Cu⁺–BCA complex is stable and measurable**.\n",
    "\n",
    "\n",
    "---\n",
    "\n",
    "## 应用说明 | Notes\n",
    "\n",
    "- 常用 BSA（牛血清白蛋白）制作标准曲线；  \n",
    "  **BSA** is used as the standard for calibration.  \n",
    "- 推荐使用空白对照（不含蛋白）扣除背景吸光度。  \n",
    "  A **blank control** is recommended to subtract background absorbance.  \n",
    "- 反应产物稳定，可在数小时内读取。  \n",
    "  The color product is **stable**, allowing flexible reading time.\n",
    "\n",
    "---\n",
    "\n",
    "## 参考文献 | Reference\n",
    "\n",
    "Smith, P. K., et al. (1985). Measurement of protein using bicinchoninic acid.  \n",
    "*Analytical Biochemistry*, 150(1), 76–85.  \n",
    "https://doi.org/10.1016/0003-2697(85)90442-7\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# 电喷雾电离（ESI）原理\n",
    "\n",
    "## 什么是 ESI？| What is Electrospray Ionization (ESI)?\n",
    "\n",
    "ESI 是一种将液体样品（如肽段溶液）转化为 **带电气相粒子** 的方法，用于质谱分析。  \n",
    "ESI is a technique that transforms liquid samples (e.g., peptide solutions) into **charged gas-phase ions** for mass spectrometry.\n",
    "\n",
    "---\n",
    "\n",
    "## 原理解释 | Step-by-Step Explanation\n",
    "\n",
    "### 1. 带电液滴喷出 | Charged Droplets Ejected\n",
    "\n",
    "- 肽段溶于水/甲醇等溶液，从一个**细金属喷嘴**喷出；\n",
    "- 喷嘴上加有高压（例如 +3000 V）；\n",
    "- 液滴被电场“充电”，带有多个正电荷（如 H⁺）；\n",
    "\n",
    "Peptide-containing droplets are sprayed from a **metal capillary** under high voltage.  \n",
    "This voltage **charges the droplets**, typically with protons (H⁺).\n",
    "\n",
    "---\n",
    "\n",
    "### 2. 液滴蒸发变小 | Droplet Shrinkage via Evaporation\n",
    "\n",
    "- 带电液滴飞行过程中，**溶剂蒸发**；\n",
    "- 液滴越来越小，但带电量不变；\n",
    "- 电荷密度逐渐升高，电斥力增强。\n",
    "\n",
    "As the solvent evaporates from the droplets, their size decreases while charge remains.  \n",
    "This leads to increased surface charge density and electrostatic repulsion.\n",
    "\n",
    "---\n",
    "\n",
    "### 3. 液滴崩解释放肽段 | Coulomb Explosion and Ion Formation\n",
    "\n",
    "- 当电斥力过大，液滴会崩解；\n",
    "- 肽段以**带电离子形式**喷出（带 1 个或多个 H⁺）；\n",
    "- 这些肽离子进入质谱仪。\n",
    "\n",
    "Eventually, the droplet **breaks apart (Coulomb explosion)** and releases **charged peptides**,  \n",
    "which then **enter the mass spectrometer** as individual ions.\n",
    "\n",
    "---\n",
    "\n",
    "## 比喻理解 | Analogy\n",
    "\n",
    "就像一个装满水的小喷壶，带着电压往外喷，**水蒸发后只剩下被“电场推动”的肽离子**进入 MS 分析。\n",
    "\n",
    "Think of ESI as a charged spray bottle: as the droplets evaporate, only **charged peptide ions** remain and fly into the MS.\n",
    "\n",
    "---\n",
    "\n",
    "## 为什么 ESI 很重要？| Why is ESI Important?\n",
    "\n",
    "- 适用于液体样品，如 LC-MS；\n",
    "- 是一种“温和电离”（soft ionization）方式，不破坏肽段；\n",
    "- 可产生多电荷离子，适合分析高质量分子。\n",
    "\n",
    "ESI is **compatible with liquid chromatography**, gentle enough to **preserve peptide integrity**,  \n",
    "and capable of producing **multiply charged ions**, enabling analysis of large biomolecules.\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## DDA 数据采集模式 | Data-Dependent Acquisition (DDA)\n",
    "\n",
    "DDA 是质谱中最常用的一种 **MS/MS 数据采集方式**，通过对前体离子（MS1）进行选择性碎裂，获得其结构信息（MS2）。  \n",
    "DDA is a common MS/MS data acquisition method that selects precursor ions from MS1 scans for fragmentation and MS2 analysis.\n",
    "\n",
    "---\n",
    "\n",
    "### 什么是 DDA？| What is DDA?\n",
    "\n",
    "- 在每个扫描周期中，质谱仪先进行一次 MS1 扫描，记录所有肽段离子的 m/z 和强度；\n",
    "- 然后从 MS1 图谱中选择**最强的 N 个离子（Top N）**，对它们进行碎裂；\n",
    "- 每个被选中的离子会进入碰撞室（collision cell），生成 MS2 碎片图谱；\n",
    "- 每秒可进行多个 MS1-MS2 扫描循环。\n",
    "\n",
    "In each cycle, the mass spectrometer:\n",
    "\n",
    "1. Performs an MS1 full scan;\n",
    "2. Selects the **top N most intense ions** for fragmentation;\n",
    "3. Acquires their MS2 spectra;\n",
    "4. Repeats this cycle throughout the LC gradient.\n",
    "\n",
    "---\n",
    "\n",
    "### 为什么要动态排除？| What is Dynamic Exclusion?\n",
    "\n",
    "#### 问题：强离子会反复被选中 ➜ 数据浪费  \n",
    "If a strong ion appears repeatedly, it may be selected again and again, wasting MS2 time.\n",
    "\n",
    "#### 解决：动态排除（Dynamic Exclusion）  \n",
    "Once an ion is selected, it is temporarily **excluded** (e.g., for 20 seconds),  \n",
    "so the instrument can focus on **lower-abundance ions**.\n",
    "\n",
    "- 优点：提升检测覆盖率，避免“看重一个离子看到死”；\n",
    "- 设置方式：排除时间（如 20–60 秒）、质量误差范围等。\n",
    "\n",
    "Dynamic exclusion prevents redundant fragmentation of the same precursor,  \n",
    "allowing broader coverage of peptides.\n",
    "\n",
    "---\n",
    "\n",
    "### 常用碎裂方式：HCD vs. CID | Fragmentation Methods: HCD vs. CID\n",
    "\n",
    "| 方法 | 中文名称 | 机制 | 特点 |\n",
    "|------|----------|------|------|\n",
    "| **CID** | 碰撞诱导解离（Collision-Induced Dissociation） | 离子撞击惰性气体（He、N₂），逐步加热断裂 | 常用于离子阱，生成 **b/y 离子** |\n",
    "| **HCD** | 高能碰撞解离（Higher-energy Collisional Dissociation） | 更高能量一次性碰撞打断 | 常用于 Orbitrap，产生清晰 MS2 图谱、适合 TMT 实验 |\n",
    "\n",
    "- CID: Traditional, slow heating, useful for ion trap instruments.\n",
    "- HCD: High-energy, beam-type fragmentation, often used on Orbitraps and TMT workflows.\n",
    "\n",
    "---\n",
    "\n",
    "### 举个例子 | Example (Top 10 + Dynamic Exclusion)\n",
    "\n",
    "- MS1 扫描检测到 1000 个带电肽段；\n",
    "- 仪器选择强度最高的 10 个进行 MS2 碎裂（Top 10）；\n",
    "- 设定“动态排除 30 秒” ➜ 同一个肽段 30 秒内不会再被碎裂；\n",
    "- 下一次扫描选择其余较强的肽段进行分析。\n",
    "\n",
    "---\n",
    "\n",
    "### 总结 | Summary\n",
    "\n",
    "DDA 是一种**基于信号强度选择性采集 MS2 数据**的策略，配合动态排除和合适的碎裂方式（CID/HCD），可有效提高蛋白质组的覆盖率和定性质量。\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# DIA 数据采集模式 | Data-Independent Acquisition (DIA)\n",
    "\n",
    "---\n",
    "\n",
    "## 什么是 DIA？| What is DIA?\n",
    "\n",
    "DIA 是一种不再“挑选前体离子”的数据采集方式，而是把**整个 m/z 范围系统性分段，每段全部碎裂**，记录所有片段信息。  \n",
    "DIA is a data acquisition strategy that **fragments all ions within defined m/z windows**, regardless of their intensity.\n",
    "\n",
    "---\n",
    "\n",
    "## DIA vs DDA 核心区别 | Key Differences: DIA vs. DDA\n",
    "\n",
    "| 特点 | DDA（数据依赖采集） | DIA（数据非依赖采集） |\n",
    "|------|---------------------|------------------------|\n",
    "| 选择方式 | Top N 强度离子 | 所有离子 |\n",
    "| 碎裂方式 | 一个一个碎（有选择） | 分段全部碎裂（无选择） |\n",
    "| 重现性 | 较低（Top N 不稳定） | 高（全段覆盖） |\n",
    "| 数据复杂度 | 简单，谱图干净 | 高度重叠，需要复杂解卷积 |\n",
    "| 常见软件 | MaxQuant, Proteome Discoverer | Spectronaut, DIA-NN, OpenSWATH |\n",
    "| 适用场景 | 鉴定为主 | 定量为主、高通量实验 |\n",
    "\n",
    "---\n",
    "\n",
    "## DIA 工作流程 | How DIA Works\n",
    "\n",
    "1. 将整个 MS1 的 m/z 范围划分为多个小窗口（如 400–1000 分为 20 个 30 m/z 窗）；\n",
    "2. 每一窗口内**所有前体离子同时碎裂**；\n",
    "3. 得到的是**混合 MS2 谱图**，包含多个肽段的碎片信息；\n",
    "4. 用**谱图库（spectral library）**或预测方法进行解卷积分析。\n",
    "\n",
    "---\n",
    "\n",
    "## 举例说明 | Example\n",
    "\n",
    "- m/z 范围：400–1000；\n",
    "- 设置 30 个 DIA 窗口，每个宽 20 m/z；\n",
    "- 扫描顺序为：\n",
    "  - Window 1: 400–420 → 所有离子碎裂；\n",
    "  - Window 2: 420–440 → 所有离子碎裂；\n",
    "  - ...\n",
    "  - Window 30: 980–1000；\n",
    "\n",
    "每个 MS2 谱图都包含多个肽段 → 数据分析需要更高算法支持。\n",
    "\n",
    "---\n",
    "\n",
    "## DIA 的优点 | Advantages of DIA\n",
    "\n",
    "- **无偏性**：不会错过低丰度肽段；\n",
    "- **高度重现性**：不同实验间一致性好；\n",
    "- **适合定量**：可用于大队列、高通量项目；\n",
    "- **兼容谱图库 / AI 预测**：如使用 DIA-NN 或 Prosit。\n",
    "\n",
    "---\n",
    "\n",
    "## DIA 的挑战 | Challenges of DIA\n",
    "\n",
    "- **谱图复杂**：MS2 是混合的，不如 DDA 干净；\n",
    "- **需要专门算法解卷积**；\n",
    "- 依赖高质量谱图库（或深度学习预测）来解释复杂信号。\n",
    "\n",
    "---\n",
    "\n",
    "## 总结 | Summary\n",
    "\n",
    "DIA 提供了一种全面、重复性强的肽段采集方式，适合于**高通量定量研究**。随着 DIA 分析工具（如 DIA-NN、Spectronaut）的发展，DIA 在蛋白质组学中已成为主流定量方法之一。\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# DDA vs. DIA：碎裂方式 & 鉴定 vs. 定量\n",
    "\n",
    "---\n",
    "\n",
    "## 一、碎裂方式对比 | Fragmentation Mode Comparison\n",
    "\n",
    "### DDA（Data-Dependent Acquisition）  \n",
    "**“一个个碎，有选择”**  \n",
    "质谱仪在 MS1 扫描后选出最强的 Top N 个离子，**逐个进行碎裂（MS2）**。  \n",
    "MS2 谱图较干净，但容易漏掉低丰度离子。\n",
    "\n",
    "> 比喻：像老师点名，“你最吵，你上台回答问题”。\n",
    "\n",
    "**DDA selects the top N most intense precursor ions from MS1 and fragments them one-by-one.**  \n",
    "This yields clean MS2 spectra but may miss low-abundance peptides.\n",
    "\n",
    "---\n",
    "\n",
    "### DIA（Data-Independent Acquisition）  \n",
    "**“分段全部碎裂，无选择”**  \n",
    "仪器把整个 m/z 范围分段（如 400–1000 Da），每段内所有离子一起碎裂。  \n",
    "MS2 是混合谱图，后期需要解卷积。\n",
    "\n",
    "> 比喻：像老师按号码段，“1~10号你们一起上来发言”。\n",
    "\n",
    "**DIA fragments all ions within predefined m/z windows simultaneously, creating complex MS2 spectra.**  \n",
    "This provides comprehensive coverage but requires advanced data processing.\n",
    "\n",
    "---\n",
    "\n",
    "## 表格总结 | Comparison Table\n",
    "\n",
    "| 特征 Feature | DDA | DIA |\n",
    "|--------------|-----|-----|\n",
    "| 离子选择 | Top N 强度 | 所有离子（分段） |\n",
    "| MS2 谱图 | 干净，容易解析 | 混合，需解卷 |\n",
    "| 漏检风险 | 高（低丰度肽可能漏掉） | 低（全面采集） |\n",
    "| 数据复杂度 | 低 | 高 |\n",
    "| 适合用途 | 鉴定为主 | 定量为主、高通量分析 |\n",
    "\n",
    "---\n",
    "\n",
    "## 二、鉴定 vs 定量 | Identification vs Quantification\n",
    "\n",
    "### 鉴定（Identification）  \n",
    "> 问题：**“这个碎片是谁？”**  \n",
    "目标是找出每条 MS2 谱图对应的肽段和蛋白。\n",
    "\n",
    "- 靠 MS2 中的 b/y 离子；\n",
    "- 比对数据库；\n",
    "- 输出：蛋白/肽段列表。\n",
    "\n",
    "**Identification asks \"What is this peptide/protein?\" using MS2 spectra and database matching.**\n",
    "\n",
    "---\n",
    "\n",
    "### 定量（Quantification）  \n",
    "> 问题：**“这个蛋白有多少？”**  \n",
    "目标是比较不同样本中相同蛋白/肽段的含量差异。\n",
    "\n",
    "- Label-free ➜ 看 MS1 峰面积；\n",
    "- TMT ➜ 看 reporter ion 强度；\n",
    "- 输出：表达量、差异表达统计。\n",
    "\n",
    "**Quantification asks \"How much of it is present?\" by comparing signal intensities across samples.**\n",
    "\n",
    "---\n",
    "\n",
    "## 对比总结 | Summary Table\n",
    "\n",
    "| 项目 | 鉴定 Identification | 定量 Quantification |\n",
    "|------|---------------------|----------------------|\n",
    "| 意义 | 这是谁？ | 有多少？ |\n",
    "| 数据来源 | MS2 碎片 | MS1 强度或 reporter ion |\n",
    "| 输出 | 蛋白/肽列表 | 表达量/丰度变化 |\n",
    "| 类比 | 谁来了？ | 来了多少人？ |\n",
    "| 关键软件 | 搜索引擎：Andromeda, SEQUEST | 定量软件：MaxQuant, DIA-NN |\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# 肽段鉴定详细解释 | Peptide Identification Explained\n",
    "\n",
    "---\n",
    "\n",
    "## 什么是肽段鉴定？| What is Peptide Identification?\n",
    "\n",
    "目标是：**根据 MS2 谱图，判断这个肽段是谁？**\n",
    "\n",
    "质谱仪不会直接告诉你氨基酸序列，只会给出一组碎片离子的质量（m/z）和强度。  \n",
    "因此我们需要通过 **数据库搜索** 来还原肽段序列。\n",
    "\n",
    "---\n",
    "\n",
    "## 1. 数据库搜索是怎么做的？| How Does Database Searching Work?\n",
    "\n",
    "### 步骤如下：\n",
    "\n",
    "1. 提供一个蛋白质数据库（如 SwissProt）；\n",
    "2. **软件工具**（如 SEQUEST, Andromeda）将数据库中的蛋白质**模拟酶切**生成所有可能的肽段；\n",
    "3. 对每条肽段模拟其理论碎片谱图（b/y 离子）；\n",
    "4. 将实验中获得的 MS2 谱图与这些理论谱图一一比对；\n",
    "5. 计算相似度得分，找出匹配最好的肽段。\n",
    "\n",
    "> 就像“看残片猜原句”：  \n",
    "> MS2 碎片 = 残缺的句子，数据库 = 所有可能的原句，  \n",
    "> 软件负责匹配：哪个原句最可能产生这些残片？\n",
    "\n",
    "---\n",
    "\n",
    "## 2. 什么是 FDR？| What is False Discovery Rate?\n",
    "\n",
    "数据库越大，随机匹配的“伪匹配”就越多。为了不把这些错配当成真结果，我们需要设置统计过滤阈值——这就是 FDR。\n",
    "\n",
    "### FDR 的定义：\n",
    "\n",
    "**在所有被认为是“真实鉴定”的结果中，有多少比例是错误的？**\n",
    "\n",
    "$$\n",
    "\\text{FDR} = \\frac{\\text{False Positives}}{\\text{All Positives}}\n",
    "$$\n",
    "\n",
    "---\n",
    "\n",
    "### 怎么估算 FDR？\n",
    "\n",
    "使用 **target-decoy 策略**：\n",
    "\n",
    "- 在数据库中加入一份“假的反向或打乱序列”（decoy）；\n",
    "- 把真实（target）和假（decoy）肽段都参与搜索；\n",
    "- 观察 decoy 匹配占比，估算整体的错误识别率。\n",
    "\n",
    "---\n",
    "\n",
    "### 举个例子：\n",
    "\n",
    "- 总共匹配出 1000 条肽段；\n",
    "- 其中 10 条匹配到了 decoy 库；\n",
    "- 则估计有 10 条 target 匹配也是错的 ➜ FDR = 10 / 1000 = **1%**\n",
    "\n",
    "所以：**设置 FDR ≤ 1% 意味着你最多接受 1% 的假阳性结果。**\n",
    "\n",
    "---\n",
    "\n",
    "## 总结表格 | Summary Table\n",
    "\n",
    "| 项目 | 内容（中文） | 内容（English） |\n",
    "|------|--------------|------------------|\n",
    "| 鉴定方法 | 数据库搜索（MS2 vs 理论肽段） | Database search (MS2 vs theoretical peptides) |\n",
    "| 工具 | SEQUEST, Andromeda | SEQUEST, Andromeda |\n",
    "| 数据库 | SwissProt, UniProt | SwissProt, UniProt |\n",
    "| 匹配依据 | b/y 离子的 m/z 与强度 | b/y ion patterns (m/z & intensity) |\n",
    "| FDR 含义 | 假阳性比例 | False discovery rate |\n",
    "| 常用 FDR 阈值 | ≤ 1% | ≤ 1% |\n",
    "\n",
    "---\n",
    "\n",
    "## 延伸阅读 | Further Reading\n",
    "\n",
    "- Elias, J. E., & Gygi, S. P. (2007). *Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry*. Nat. Methods, 4(3), 207–214.  \n",
    "  https://doi.org/10.1038/nmeth1019\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Peptide Identification 中谱图匹配的数学原理\n",
    "\n",
    "---\n",
    "\n",
    "## 1. 问题背景 | Problem Setting\n",
    "\n",
    "在质谱（MS/MS）中，我们的目标是根据实验获得的 MS2 谱图，识别出最可能的肽段序列。  \n",
    "This requires comparing the experimental MS2 spectrum to many theoretical spectra and **scoring their similarity**.\n",
    "\n",
    "---\n",
    "\n",
    "## 2. 向量表示谱图 | Representing Spectra as Vectors\n",
    "\n",
    "我们可以将谱图离散化成向量的形式，令：\n",
    "\n",
    "$$\n",
    "S_{\\text{exp}} = [I_1^{\\text{(exp)}}, I_2^{\\text{(exp)}}, \\ldots, I_n^{\\text{(exp)}}]\n",
    "$$\n",
    "\n",
    "$$\n",
    "S_{\\text{theory}} = [I_1^{\\text{(theory)}}, I_2^{\\text{(theory)}}, \\ldots, I_n^{\\text{(theory)}}]\n",
    "$$\n",
    "\n",
    "其中第 \\( i \\) 个元素表示某个 m/z 区间（bin）上的离子强度。\n",
    "\n",
    "\n",
    "---\n",
    "\n",
    "## 3. 匹配打分方法 | Matching Score Methods\n",
    "\n",
    "### 3.1 Dot Product（向量内积）\n",
    "\n",
    "$$\n",
    "\\text{DotScore} = \\sum_{i=1}^{n} I_i^{\\text{(exp)}} \\cdot I_i^{\\text{(theory)}}\n",
    "$$\n",
    "\n",
    "- 度量两个谱图在每个 m/z 上的强度一致性；\n",
    "- 如果强度在相同位置都很高，则分数高；\n",
    "- 常用于余弦相似度计算（见下）。\n",
    "\n",
    "---\n",
    "\n",
    "### 3.2 Cosine Similarity（余弦相似度）\n",
    "\n",
    "$$\n",
    "\\text{CosineScore} = \\frac{\\sum_{i=1}^{n} I_i^{\\text{(exp)}} \\cdot I_i^{\\text{(theory)}}}{\\sqrt{\\sum_{i=1}^{n} \\left(I_i^{\\text{(exp)}}\\right)^2} \\cdot \\sqrt{\\sum_{i=1}^{n} \\left(I_i^{\\text{(theory)}}\\right)^2}}\n",
    "$$\n",
    "\n",
    "- 归一化后计算两个谱图夹角的余弦；\n",
    "- 接近 1 表示高度相似。\n",
    "\n",
    "---\n",
    "\n",
    "### 3.3 XCorr（交叉相关打分）数学定义\n",
    "\n",
    "XCorr（Cross-correlation score）是 SEQUEST 中用于谱图匹配的鲁棒打分方式，基本思想是：\n",
    "\n",
    "> **将实验谱图与理论谱图对齐后计算匹配强度（RawScore），再减去其“随机错位匹配”的平均强度（ExpectedBackground），提高抗噪性能。**\n",
    "\n",
    "\n",
    "#### 原始匹配得分（Raw Score）\n",
    "\n",
    "$$\n",
    "\\text{RawScore} = \\sum_{k=1}^{n} x_k \\cdot y_k\n",
    "$$\n",
    "\n",
    "- \\( x_k \\)：理论谱图向量中的第 \\( k \\) 个 bin，通常为 0 或 1，表示是否有预测碎片；\n",
    "- \\( y_k \\)：实验谱图向量中的第 \\( k \\) 个 bin 的离子强度。\n",
    "\n",
    "\n",
    "#### 背景期望（Expected Background）\n",
    "\n",
    "为估计“随机匹配”的平均值，SEQUEST 计算错位后的匹配情况：\n",
    "\n",
    "$$\n",
    "\\text{ExpectedBackground} = \\frac{1}{2L + 1} \\sum_{\\delta = -L}^{L} \\sum_{k=1}^{n} x_k \\cdot y_{k + \\delta}, \\quad \\delta \\ne 0\n",
    "$$\n",
    "\n",
    "- \\( \\delta \\)：滑动偏移量（shift），表示谱图错位的程度；\n",
    "- 排除 \\(\\delta = 0\\) 是因为那就是正对齐（RawScore），不能算背景；\n",
    "- 总共用了 \\( 2L \\) 个非中心位置（前 \\( L \\) 个 + 后 \\( L \\) 个）；\n",
    "- **加上中心 \\(\\delta = 0\\)** 一共是 \\( 2L + 1 \\) 项，所以为了取“平均”，分母设为 \\( 2L + 1 \\)。\n",
    "\n",
    "> ⚠️ **注意**：虽然 \\(\\delta = 0\\) 被排除在求和之外，但分母仍设为 \\( 2L + 1 \\)（而不是 \\( 2L \\)），\n",
    "> 这是因为 SEQUEST 设计中为了标准化背景分数，使其能与 RawScore 直接做差时有更平衡的尺度。\n",
    "\n",
    "\n",
    "#### 最终打分公式（XCorr）\n",
    "\n",
    "$$\n",
    "\\text{XCorr} = \\text{RawScore} - \\text{ExpectedBackground}\n",
    "$$\n",
    "\n",
    "- 如果某个肽段的匹配是“真实的”，那么正对齐的得分（RawScore）应远高于随机错位匹配（背景）；\n",
    "- 所以 XCorr 会高；\n",
    "- 如果是随机匹配，RawScore 与背景相似，XCorr 会接近 0。\n",
    "\n",
    "\n",
    "#### 实验谱图预处理（补充）\n",
    "\n",
    "在实际实现中，为了避免强峰主导得分，SEQUEST 会对 \\( y_k \\) 做如下归一化：\n",
    "\n",
    "- 强度归一化（sqrt scaling）：\\( y_k \\leftarrow \\sqrt{y_k} \\)\n",
    "- 或最大值缩放（normalization）：\\( y_k \\leftarrow \\frac{y_k}{\\max(y)} \\)\n",
    "\n",
    "\n",
    "---\n",
    "\n",
    "## 4. 是不是期望？| Is the dot product an expectation?\n",
    "\n",
    "$$\n",
    "\\sum_{i=1}^{n} I_i^{\\text{(exp)}} \\cdot I_i^{\\text{(theory)}}\n",
    "$$\n",
    "\n",
    "这不是统计学意义上的期望（expectation），因为：\n",
    "\n",
    "- 没有概率权重；\n",
    "- 不是对随机变量的加权平均；\n",
    "- 它是 **线性代数中的内积操作**（dot product），衡量谱图向量对齐程度。\n",
    "\n",
    "---\n",
    "\n",
    "## 参考资料 | References\n",
    "\n",
    "- Eng, J. K., McCormack, A. L., & Yates, J. R. (1994). *An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database*. JASMS.\n",
    "- Cox, J., & Mann, M. (2008). *MaxQuant enables high peptide identification rates...*. Nat Biotech.\n",
    "- Frank, A., & Pevzner, P. (2005). *PepNovo: de novo peptide sequencing via probabilistic network modeling*. Anal Chem.\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 5. 蛋白定量 | Protein Quantification\n",
    "\n",
    "---\n",
    "\n",
    "### Label-Free Quantification (LFQ) 是什么？\n",
    "\n",
    "LFQ 是通过 MS1 色谱峰面积来估算肽段在样本中的丰度：\n",
    "\n",
    "- 对每个肽段，提取其 **XIC（Extracted Ion Chromatogram）**；\n",
    "- 计算保留时间区间内的峰面积；\n",
    "- 面积大小反映该肽段在样本中的丰度（相对量）。\n",
    "\n",
    "---\n",
    "\n",
    "### ✅ 什么能比较？\n",
    "\n",
    "- 同一个肽段，在不同样本之间的强度变化  \n",
    "  ✅ 可以比较，因为它们经历了相同的电离和检测过程\n",
    "\n",
    "- 同一个蛋白的多个肽段，在不同样本中汇总后的平均  \n",
    "  ✅ 通常可以比较（通过多个肽段平均误差）\n",
    "\n",
    "---\n",
    "\n",
    "### ❌ 什么不能直接比较？\n",
    "\n",
    "- 不同肽段之间的强度大小  \n",
    "  ❌ 不可以比较，因为它们的电离效率、色谱行为等不同\n",
    "\n",
    "- 不同蛋白之间的总强度大小  \n",
    "  ❌ 通常不建议比较，除非做过归一化和标准化\n",
    "\n",
    "---\n",
    "\n",
    "### 📉 为什么不同肽段不能直接比较？\n",
    "\n",
    "#### 1. 离子化效率不同（Ionization Efficiency）\n",
    "\n",
    "- 不同肽段带电能力差异大（如含多个 K/R 的更容易电离）；\n",
    "- 即使浓度一样，强度可能差别 10 倍以上。\n",
    "\n",
    "#### 2. 色谱行为不同（Retention Profile）\n",
    "\n",
    "- 峰展宽 vs. 峰集中，面积和峰值关系不同；\n",
    "- 对比瞬时强度易受干扰。\n",
    "\n",
    "#### 3. 仪器响应曲线差异\n",
    "\n",
    "- 不同 m/z 的检测灵敏度略有偏差；\n",
    "- 大肽段或带多电荷的响应可能偏低。\n",
    "\n",
    "---\n",
    "\n",
    "### 📐 数学表达\n",
    "\n",
    "对于肽段 \\( P \\)，在样本 \\( i \\) 中的 MS1 强度记为：\n",
    "\n",
    "$$\n",
    "\\text{Intensity}_{P, i} = k_P \\cdot A_{P, i}\n",
    "$$\n",
    "\n",
    "其中：\n",
    "\n",
    "- \\( A_{P, i} \\)：第 \\( i \\) 个样本中该肽段的实际丰度；\n",
    "- \\( k_P \\)：肽段 \\( P \\) 的电离常数（未知但固定）；\n",
    "\n",
    "因此：\n",
    "\n",
    "- 对于同一肽段比较不同样本：\n",
    "  \n",
    "  $$\n",
    "  \\frac{\\text{Intensity}_{P, i}}{\\text{Intensity}_{P, j}} = \\frac{A_{P, i}}{A_{P, j}} \\quad \\text{（可比较）}\n",
    "  $$\n",
    "\n",
    "- 但对于两个不同肽段 \\( P \\) 和 \\( Q \\)：\n",
    "\n",
    "  $$\n",
    "  \\frac{\\text{Intensity}_{P}}{\\text{Intensity}_{Q}} = \\frac{k_P \\cdot A_P}{k_Q \\cdot A_Q} \\quad \\text{（不可比较）}\n",
    "  $$\n",
    "\n",
    "---\n",
    "\n",
    "### ✅ 总结 | Summary\n",
    "\n",
    "| 比较对象 | 是否推荐？ | 原因 |\n",
    "|-----------|--------------|--------|\n",
    "| 同一肽段在不同样本中的强度 | ✅ 可以 | 电离效率相同，可反映相对丰度 |\n",
    "| 同一蛋白在不同样本中（多个肽段汇总） | ✅ 可以 | 误差可平均 |\n",
    "| 不同肽段之间的强度 | ❌ 不推荐 | 电离行为不同 |\n",
    "| 不同蛋白之间的总强度 | ❌ 不推荐 | 缺乏统一标准，误差大 |\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 什么是 XIC 面积？| What is XIC Area?\n",
    "\n",
    "XIC（Extracted Ion Chromatogram）面积是定量质谱中的关键指标：\n",
    "\n",
    "- 对某个 m/z 匹配的肽段，提取其在 LC-MS 过程中的保留时间窗口；\n",
    "- 在该窗口内记录 MS1 层上的信号强度曲线；\n",
    "- 对该强度曲线积分，得到面积；\n",
    "- 面积越大，说明该肽段在样本中的丰度越高。\n",
    "\n",
    "---\n",
    "\n",
    "### 数学表达 | Mathematical Expression\n",
    "\n",
    "令：\n",
    "\n",
    "- \\( I(t) \\)：在时间 \\( t \\) 上某个 m/z 的 MS1 信号；\n",
    "- \\( t_1, t_2 \\)：肽段色谱峰的开始和结束时间；\n",
    "\n",
    "则 XIC 面积为：\n",
    "\n",
    "$$\n",
    "A = \\int_{t_1}^{t_2} I(t) \\, dt\n",
    "$$\n",
    "\n",
    "在实际采样中，用离散求和近似：\n",
    "\n",
    "$$\n",
    "A \\approx \\sum_{t = t_1}^{t_2} I(t) \\cdot \\Delta t\n",
    "$$\n",
    "\n",
    "---\n",
    "\n",
    "### 说明 | Notes\n",
    "\n",
    "- 面积越大，肽段浓度越高（相对）；\n",
    "- 同一个肽段跨样本比较是可靠的；\n",
    "- 但不同肽段面积不可直接比较（见前节说明）。\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## MS1 信号的函数模型 | Mathematical Shape of MS1 Signal\n",
    "\n",
    "---\n",
    "\n",
    "### 什么是 MS1 信号？\n",
    "\n",
    "MS1 信号指的是在质谱一级（MS1）中，**某个特定 m/z 离子**在随时间变化过程中的信号强度：\n",
    "\n",
    "- 每次 LC-MS 扫描时记录该 m/z 的强度；\n",
    "- 连续扫描获得其随时间的强度变化；\n",
    "- 称为 **XIC（Extracted Ion Chromatogram）** 曲线。\n",
    "\n",
    "---\n",
    "\n",
    "### MS1 信号长什么样？| What Does MS1 Signal Look Like?\n",
    "\n",
    "在色谱过程中，肽段被洗脱出来时会形成一个“峰”：\n",
    "\n",
    "- 通常是近似 **高斯分布（Gaussian peak）**；\n",
    "- 有时存在拖尾（tailing） ➜ 类似于 **偏高斯峰** 或 **EMG（Exponentially Modified Gaussian）**。\n",
    "\n",
    "---\n",
    "\n",
    "### 理想模型：高斯函数 | Ideal Case: Gaussian Function\n",
    "\n",
    "$$\n",
    "I(t) = A \\cdot \\exp\\left( -\\frac{(t - t_r)^2}{2\\sigma^2} \\right)\n",
    "$$\n",
    "\n",
    "- \\( I(t) \\)：保留时间 \\( t \\) 时的 MS1 强度；\n",
    "- \\( A \\)：峰高（最大信号强度）；\n",
    "- \\( t_r \\)：色谱保留时间（肽段流出的中心时间）；\n",
    "- \\( \\sigma \\)：峰宽，决定峰的扩散程度。\n",
    "\n",
    "---\n",
    "\n",
    "### 实际模型：Exponentially Modified Gaussian（EMG）\n",
    "\n",
    "考虑洗脱过程中出现拖尾，实际模型可以使用 EMG 表示：\n",
    "\n",
    "$$\n",
    "I(t) = A \\cdot \\exp\\left( -\\frac{t - t_r}{\\tau} \\right) \\cdot \\Phi\\left( \\frac{t - t_r}{\\sigma} \\right)\n",
    "$$\n",
    "\n",
    "其中：\n",
    "\n",
    "- \\( \\Phi(\\cdot) \\)：标准正态分布的累积分布函数（CDF）；\n",
    "- \\( \\tau \\)：指数衰减项，控制拖尾程度；\n",
    "- 当 \\( \\tau \\to \\infty \\) 时恢复为标准高斯。\n",
    "\n",
    "---\n",
    "\n",
    "### 为什么是峰形？| Why Is It Peak-Shaped?\n",
    "\n",
    "- LC（液相色谱）使肽段按疏水性分离，每种肽段在特定时间洗脱；\n",
    "- 这个时间窗口内，该 m/z 的信号会出现强度上升 → 峰值 → 下降；\n",
    "- MS1 连续采集信号就形成了时间轴上的峰曲线。\n",
    "\n",
    "---\n",
    "\n",
    "### 应用：XIC 面积定量\n",
    "\n",
    "提取该峰区间的积分面积作为相对丰度指标：\n",
    "\n",
    "$$\n",
    "\\text{XIC Area} = \\int_{t_1}^{t_2} I(t) \\, dt \\approx \\sum_{i=1}^{n} I(t_i) \\cdot \\Delta t\n",
    "$$\n",
    "\n",
    "- XIC 面积反映该肽段被检测到的“总量”；\n",
    "- 只在同一个肽段不同样本中具有可比性。\n",
    "\n",
    "---\n",
    "\n",
    "### 总结 | Summary\n",
    "\n",
    "| 属性 | 模型 | 特征 |\n",
    "|------|------|------|\n",
    "| 理想信号 | 高斯函数 | 对称峰 |\n",
    "| 实际信号 | EMG 模型 | 拖尾偏移 |\n",
    "| 用途 | XIC 积分定量 | 面积与丰度相关 |\n",
    "\n"
   ]
  }
 ],
 "metadata": {
  "language_info": {
   "name": "python"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
